Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Drug Resistance

  Free Subscription


03.09.2018

1 Antimicrob Agents Chemother
1 Infect Control Hosp Epidemiol
12 Int J Antimicrob Agents
2 J Antimicrob Chemother
2 J Med Microbiol
3 Lancet Infect Dis
2 N Engl J Med
2 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. BALLABEN AS, Andrade LN, Galetti R, Ferreira JC, et al
    Diversity of high-level aminoglycoside resistance mechanisms among Gram-negative nosocomial pathogens in Brazil.
    Antimicrob Agents Chemother. 2018 Aug 27. pii: AAC.01550.
    PubMed     Text format     Abstract available


    Infect Control Hosp Epidemiol

  2. ROCK C, Anderson M, Lewis S, Scheeler V, et al
    Comparison of nylon-flocked swab and cellulose sponge methods for carbapenem-resistant Enterobacteriaceae and gram-negative organism recovery from high-touch surfaces in patient rooms.
    Infect Control Hosp Epidemiol. 2018 Aug 28:1-5. doi: 10.1017/ice.2018.
    PubMed     Text format     Abstract available


    Int J Antimicrob Agents

  3. LI R, Yu H, Xie M, Chen K, et al
    Genetic basis of chromosomally-encoded mcr-1 gene.
    Int J Antimicrob Agents. 2018;51:578-585.
    PubMed     Text format     Abstract available

  4. LISHMAN H, Costelloe C, Hopkins S, Johnson AP, et al
    Exploring the relationship between primary care antibiotic prescribing for urinary tract infections, Escherichia coli bacteraemia incidence and antibiotic resistance: an ecological study.
    Int J Antimicrob Agents. 2018 Aug 23. pii: S0924-8579(18)30239.
    PubMed     Text format     Abstract available

  5. RAOULT D
    The theory of "Eat me cake", or the genetic cannibalism of the enemy: a cause of vanishing antibiotic resistance.
    Int J Antimicrob Agents. 2018 Aug 24. pii: S0924-8579(18)30244.
    PubMed     Text format    

  6. LINDGREN AK, Nilsson AC, Akesson P, Gustafsson E, et al
    Eradication of methicillin-resistant Staphylococcus aureus (MRSA) throat carriage: a randomised trial comparing topical treatment with rifampicin-based systemic therapy.
    Int J Antimicrob Agents. 2018;51:642-645.
    PubMed     Text format     Abstract available

  7. TIETGEN M, Semmler T, Riedel-Christ S, Kempf VAJ, et al
    Impact of the colistin resistance gene mcr-1 on bacterial fitness.
    Int J Antimicrob Agents. 2018;51:554-561.
    PubMed     Text format     Abstract available

  8. NGUYEN PC, Madani A, Santucci P, Martin BP, et al
    Cyclophostin and Cyclipostins analogues, new promising molecules to treat mycobacterial-related diseases.
    Int J Antimicrob Agents. 2018;51:651-654.
    PubMed     Text format     Abstract available

  9. PFALLER MA, Flamm RK, Castanheira M, Sader HS, et al
    Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011-2016).
    Int J Antimicrob Agents. 2018;51:608-611.
    PubMed     Text format     Abstract available

  10. CARRARA E, Pfeffer I, Zusman O, Leibovici L, et al
    Determinants of inappropriate empirical antibiotic treatment: systematic review and meta-analysis.
    Int J Antimicrob Agents. 2018;51:548-553.
    PubMed     Text format     Abstract available

  11. HUANG J, Zhu Y, Han ML, Li M, et al
    Comparative analysis of phosphoethanolamine transferases involved in polymyxin resistance across 10 clinically relevant Gram-negative bacteria.
    Int J Antimicrob Agents. 2018;51:586-593.
    PubMed     Text format     Abstract available

  12. VARDAKAS KZ, Mavroudis AD, Georgiou M, Falagas ME, et al
    Intravenous colistin combination antimicrobial treatment vs. monotherapy: a systematic review and meta-analysis.
    Int J Antimicrob Agents. 2018;51:535-547.
    PubMed     Text format     Abstract available

  13. OHNUMA T, Hayashi Y, Yamashita K, Marquess J, et al
    A nationwide survey of intravenous antimicrobial use in intensive care units in Japan.
    Int J Antimicrob Agents. 2018;51:636-641.
    PubMed     Text format     Abstract available

  14. ADHIKARI S, Piza M, Taylor P, Deshpande K, et al
    Sustained multimodal antimicrobial stewardship in an Australian tertiary intensive care unit from 2008-2015: an interrupted time-series analysis.
    Int J Antimicrob Agents. 2018;51:620-628.
    PubMed     Text format     Abstract available


    J Antimicrob Chemother

  15. CAMARA J, Cubero M, Martin-Galiano AJ, Garcia E, et al
    Evolution of the beta-lactam-resistant Streptococcus pneumoniae PMEN3 clone over a 30 year period in Barcelona, Spain.
    J Antimicrob Chemother. 2018 Aug 27. pii: 5079858. doi: 10.1093.
    PubMed     Text format     Abstract available

  16. MACFADYEN AC, Harrison EM, Ellington MJ, Parkhill J, et al
    A highly conserved mecC-encoding SCCmec type XI in a bovine isolate of methicillin-resistant Staphylococcus xylosus.
    J Antimicrob Chemother. 2018 Aug 27. pii: 5084893. doi: 10.1093.
    PubMed     Text format    


    J Med Microbiol

  17. HOSSEINKHANI F, Tammes Buirs M, Jabalameli F, Emaneini M, et al
    High diversity in SCCmec elements among multidrug-resistant Staphylococcus haemolyticus strains originating from paediatric patients; characterization of a new composite island.
    J Med Microbiol. 2018 Jun 6. doi: 10.1099/jmm.0.000776.
    PubMed     Text format     Abstract available

  18. SHANKAR C, Shankar BA, Manesh A, Veeraraghavan B, et al
    KPC-2 producing ST101 Klebsiella pneumoniae from bloodstream infection in India.
    J Med Microbiol. 2018;67:927-930.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  19. FRIEDLAND JS, Hargreaves S
    Antimicrobial resistance among migrants in Europe - Authors' reply.
    Lancet Infect Dis. 2018;18:945.
    PubMed     Text format    

  20. JEE Y, Carlson J, Rafai E, Musonda K, et al
    Antimicrobial resistance: a threat to global health.
    Lancet Infect Dis. 2018;18:939-940.
    PubMed     Text format    

  21. VAN HECKE O, Lee JJ, O'Sullivan JW
    Antimicrobial resistance among migrants in Europe.
    Lancet Infect Dis. 2018;18:944.
    PubMed     Text format    


    N Engl J Med

  22. EMU B, Fessel J, Schrader S, Kumar P, et al
    Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1.
    N Engl J Med. 2018;379:645-654.
    PubMed     Text format     Abstract available

  23. SHEIKH V, Murray JS, Sherwat A
    Ibalizumab in Multidrug-Resistant HIV - Accepting Uncertainty.
    N Engl J Med. 2018;379:605-607.
    PubMed     Text format    


    Proc Natl Acad Sci U S A

  24. NYERGES A, Csorgo B, Draskovits G, Kintses B, et al
    Directed evolution of multiple genomic loci allows the prediction of antibiotic resistance.
    Proc Natl Acad Sci U S A. 2018;115:E5726-E5735.
    PubMed     Text format     Abstract available

  25. BEHRINGER MG, Choi BI, Miller SF, Doak TG, et al
    Escherichia coli cultures maintain stable subpopulation structure during long-term evolution.
    Proc Natl Acad Sci U S A. 2018;115:E4642-E4650.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: